Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection

Frederik Trinkmann, Michael Müller, Alexandra Reif, Nicolas Kahn, Michael Kreuter, Franziska Trudzinski, Monika Eichinger, Claus-Peter Heussel, Felix J.F. Herth

Source: Eur Respir J, 57 (2) 2003002; 10.1183/13993003.03002-2020
Journal Issue: February
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Frederik Trinkmann, Michael Müller, Alexandra Reif, Nicolas Kahn, Michael Kreuter, Franziska Trudzinski, Monika Eichinger, Claus-Peter Heussel, Felix J.F. Herth. Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection. Eur Respir J, 57 (2) 2003002; 10.1183/13993003.03002-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at the time of diagnosis
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019


Why does chronic bronchitis and lung infection accelerate lung function decline
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021


Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with high and low reversibility
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017


Prediction of respiratory disease mortality in a population sample is improved by expressing lung function impairment as FEV1 quotient
Source: Eur Respir J 2005; 26: Suppl. 49, 217s
Year: 2005

Subclinical structural or functional lung changes is associated with higher risk of developing lower respiratory tract infection in a tertiary RA cohort.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma
Source: ERJ Open Res, 6 (1) 00204-2019; 10.1183/23120541.00204-2019
Year: 2020



Relationship between FEV1 reduction and respiratory symptoms in the general population
Source: Eur Respir J 2003; 21: 658-663
Year: 2003



Monitoring of pediatric asthma by symptoms and lung function versus symptoms, lung function and exhaled NO
Source: Annual Congress 2004 - Monitoring childhood asthma
Year: 2004


Correlation between exercise capacity with FVC%, FEV1% and RV% in patients with airways diseases and severe and very severe lung function obstruction
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016

Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018


Functional residual capacity and lung diffusion capacity in calves with chronic airflow obstruction caused by persistent chlamydial infection
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008

Impact of bacterial colonization in lower respiratory tract on fibrile episode in patietns with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 1s
Year: 2003

Screening the general population for lung function abnormalities: yield of respiratory symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 261s
Year: 2002

Predicting the pulmonary function after upper and lower lobectomy for lung cancer in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 173s
Year: 2005

Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008

Lung function in patients with different infecting agents caused acute exacerbation of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 337s
Year: 2003

Ensifentrine added on to tiotropium significantly improves lung function, symptoms and QoL in symptomatic COPD patients regardless of baseline reversibility
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020


Measuring and enhancing physical activity in patients with chronic lung disease
Source: Eur Respir Monogr 2021; 93: 195-204
Year: 2021


The longitudinal relationship between bacterial load airway inflammation and lung function decline in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002